Q4 2024 Earnings Call Transcript March 20, 2025 Amprius Technologies, Inc. beats earnings expectations. Reported EPS is $-0.1 ...

Welcome to the Amprius Technologies fourth quarter and full-year 2024 earnings conference call. Joining us for today's presentation are the company's CEO, Dr. Kang Sun; and CFO, Sandra Wallach.

Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite development company ("Westwater" or the "Company"), is pleased to announce its results for the ...

Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical ...

Luminar , a leading global automotive technology company, provided its quarterly business update and financial results for the fourth quarter and full year of 2024. These results and related ...

Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission - - Strengthened ...

Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter ...

Good afternoon, and welcome to the Trevi Therapeutics fourth-quarter and year-end 2024 earnings conference call. (Operator Instructions) Please note, this event is being recorded. Various remarks that ...

Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development ...

It’s been a rocky start to the year and household confidence levels have taken a knock. The Westpac-McDermott Miller Consumer Confidence Index fell 8 points in March to a level of 89.2.

Independent mortgage banks (IMBs) and the mortgage divisions of chartered banks reported an average pre-tax net loss of $40 ...

Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...